Skip to main content
. 2024 Aug 23;16(8):4892–4903. doi: 10.21037/jtd-24-298

Table 3. Association of BAR with 30-day mortality.

Exposure Non-adjusted Adjust I Adjust II
HR (95% CI) P value HR (95% CI) P value HR (95% CI) P value
BUN 1.01 (1.01, 1.01) <0.001 1.01 (1.00, 1.01) <0.0001 1.00 (1.00, 1.01) <0.001
Albumin 0.77 (0.72, 0.82) <0.001 0.76 (0.71, 0.81) <0.0001 0.87 (0.81, 0.94) <0.001
BAR per 1sd 1.02 (1.01, 1.02) <0.001 1.02 (1.01, 1.02) <0.0001 1.01 (1.01, 1.02) <0.001
BAR tertile
   Low (ref) 1.0 1.0 1.0
   Middle 1.39 (1.22, 1.59) <0.001 1.24 (1.08, 1.42) 0.0024 1.03 (0.89, 1.18) 0.71
   High 1.79 (1.57, 2.03) <0.001 1.60 (1.40, 1.82) <0.0001 1.28 (1.10, 1.49) 0.002
BAR categorical
   ≤11.76 mg/g (ref) 1.0 1.0 1.0
   >11.76 mg/g 1.54 (1.39, 1.70) <0.001 1.45 (1.31, 1.60) <0.0001 1.29 (1.15, 1.45) <0.001

Adjusted I for age, gender and ethnicity. Adjusted II for age, gender and ethnicity, malignant cancer, severe liver disease, creatine, WBC, platelets, SOFA, mechanical ventilation and vasoactive use. BAR, blood urea nitrogen-to-albumin ratio; HR, hazard ratio; CI, confidence interval; BUN, blood urea nitrogen; ref, reference; WBC, white blood cell; SOFA, sequential organ failure assessment.